Диссертация (1174291), страница 27
Текст из файла (страница 27)
– 2016. –Vol. 31, N 11. – P. 2487-2494.225.Marks, R. Body mass characteristics of hip osteoarthritis patientsexperiencing aseptic loosening, periprosthetic fractures, dislocation, and infections aftertotal hi p replacement / R. Marks // Clinicoecon. Ou tcomes Res. – 2009.
–Vol. 1. – P. 716.226.Marsh, J. Older patients can accurately recall their preoperative healthstatus six weeks following total hip arthroplasty / J. Marsh, D. Bryant, S.J. Macdonald //J. Bone Joint Surg. – 2009. – Vol. 91, N 12. – P. 28 27 – 2837.227.Masterson, S.
Impaction femoral allografting at revision hip arthroplasty:uncemented versus cemented technique using a Freeman femoral component /S. Masterson, S. Lidder, G. Scott // J. Bone Joint Surg. – 2012. – Vol. 94-B, N 1. – P.51-55.228.McGarry, S.A. Surgical-site infection due to Staphylococcus aureus amongelderly patients: mortality, duration of hospitalization, and cost / S.A. McGarry, J.J.Engemann, K. Schmader [et al.] // Infect. Control. Hosp. Epidemiol. – 2004.
– Vol. 25,N 6. – P. 461-467.169229.McHugh, S.M. The role of topical antibiotics used as prophylaxis insurgical site infection prevention / S.M. McHugh, C.J. Collins, M.A. Corrigan [et al.] //J. Antimicrob. Chemother. – 2011. – Vol. 66, N 4. – P. 693-701.230.McLaren, A.C. The effect of sampling method on the elution of to bramycinfrom c lcium sulfate / A.C.
McLaren, S.G. McLaren, C.L. Nelson [et al.] // Clin. Orthop.Relat. Res. – 2002. – Vol. 403, N 8. – P. 54-57.231.McLaren, A.C. Xylitol and glycine fillers increase permeability of PMMAto enhance elution of daptomycin / A.C. McLaren, S.G. McLaren, M. Smeltzer // Clin.Orthop. Relat. Res. – 2006. –Vol. 451, N 10. – P. 25-28.232.Minelli, E.B. Release of gentamicin and vancomycin from temporaryhuman hip spacers in two-stage revision of infected arthroplasty / E.B. Minelli, A.Benini, B.
Magnan, P. Bartolozzi // J. Antimicrob. Chemother. – 2004. – Vol. 53, N 2. –P. 329-334.233.Mittal, Y. Two-stage reimplantation for periprosthetic knee infection involving resistant organisms / Y. Mittal, T.K. Fehring, A. Hanssen [et al.] // J. Bone JointSurg. Аm. – 2007. – Vol. 89, N 6. – Р. 1227-1231.234.Momohara, S. Prosthetic joint infection af ter to tal hip or knee ar throplastyin rheumatoid arthritis patients treated with nonbiologic and biologic disease-modifyingantirheumatic drugs / S. Momohara, K. awakami, T. Iwamoto [et al.] // Mod.Rheumatol.
– 2011. – Vol. 21, N 5. – P. 469-475.235.Mont, M.A. The natural history of untreated asymptomatic osteonecrosis ofthe femoral head: a systematic literature review // M.A. Mont, M.G. Zywiel, D.R.Marker [et al.] // J. Bone Joint Surg. – 2010. – Vol. 92-A, N 12. – P. 21 65 – 2170.236.Moore, A.T. Metal hip joint. A case report / A.T. Moore, H.R. Bohlman //J. Bone Joint Surg.
Am. – 1943. – Vol. 25, N 3. – P. 68 8-692.237.Moran, E. The diagnosis and management of prosthetic joint infections / E.Moran, I. Byren, B.L. Atkins // J. Antimicrob. Chemother. – 2010. – Vol. 65, Suppl. 3.– Р. 45-54.170238.Mortazavi, S.M.J. Perioperative stroke after total joint arthroplasty:prevalence, predictors, and outcome / S.M.J. Mortazavi, H. Kakli, O. Bican [et al.] // J.Bone Joint Surg. – 2010. – Vol. 92-A, N 11. – P. 20 95-2101.239.Moyad, T.F. Evaluation and management of the infected total hip and knee/ T.F.
Moyad, T. Thornhill, D. Estok // Orthopedics. – 2008. – Vol. 31, N 6. – Р. 581588.240.Murillo, O. The changing epidemiology of bacteraemic osteoarticularinfections in the early 21th century / O. Murillo, A. Gr au, J. Lo ra-Tamayo [et al.] //Clin. Mi crobiol. Infect. – 2015. – Vol. 21, N 3. – P.254.e1-8.241.Namba, R.S. Risk factors associated with surgical site infection in 30491primary total hip replacements / R.S. Namba, M.C.S. Inacio, E.W. Paxton // J. BoneJoint Surg. – 2012. – Vol. 94-B, N 10. – P.
13 30 – 1338.242.Namdari, S. Primary total joint ar throplasty performed in operating roomsfollowing cases of known infection / S. Namdari, P.B. Voleti, K.D. Baldwin, G.C. Lee// Orthopedics. – 2011. – Vol. 34, N 9. – P. 541-545.243.Nath, R. Primary cemented total hip arthroplasty: 10 years follow-up / R.Nath, A.K. Gupta, U. Chakravarty [et al.] // Indian J. Orthop. – 2010. – Vol.
44, N 3 –P. 283–288.244.Netval, M. Hip replacement after tuberculous coxitis. Twenty-seven-yearexperience (1980-2007) / M. Netval, N. Tawa, D. Chocholác // Acta Chir. Orthop.Traumatol. Cech. – 2008. – Vol. 75, N 6. – Р. 446-450.245.Obituary Mr. Anthony White // Lancet. – 1849. – Vol.
53, N 1334. – P.324-325.246.Papadopoulos, A. Efficacy and tolerability of linezolid in chronicosteomyelitis and prosthetic joint infections: a case-control study / A. Papadopoulos, D.Plachouras, E. Giannitsioti [et al.] // J. Chemother. – 2009. – Vol. 21, N 2. – Р. 165-169.247.Paprosky, W.G. Classification of bone defects in failed prostheses / W.G.Paprosky, M.S. Bradford, T.I. Yo unger // Chir.
Organi Mov. – 1994. – Vol. 79. – Р.285-291.171248.Park, Y.S. Ceramic failure after total hip arthroplasty with alumina-on-alumina bearing / Y.S. Park, S.K. Hwang, W.S. Choy [et al.] // J. Bone Joint Surg. –2006. – Vol. 88-A, N 4. – P. 78 0 – 787.249.Parvizi, J. AAOS clinical practice guideline: diagnosis and treatment ofperiprosthetic joint infections of th e hi p an d kn ee / J. Parvizi, C.J. Della Va lle // J. Am.Acad.
Orthop. Surg. – 2010. – Vol. 18, N 12. – P. 771-772.250.Parvizi, J. New definition for periprosthetic joint infection: from theWorkgroup of the Musculoskeletal Infection Society / J. Parvizi, B. Zmistowski, E.F.Berbari [et al.] // Clin. Orthop. Relat. Res. – 2011. – Vol. 469, N 11. – P. 2992-2994.251.Parvizi, J.
Management of Periprothetic Joint Infection: Thee CurrentKnowledge / J. Parvizi, B. Adeli, B. Zmitovski [et al.] // J. Bone Joint Surg. Am. –2012. – Vol. 94, N 14. – P. e104.252.Pedersen, A.B. Sh ort- and long-term mortality following primary total hipreplacement for osteoarthritis: A danish nationwide epidemiological study / A.B.Pedersen, J.A. Baron, S. Overgaard, S.P. Johnsen // J. Bone Joint Surg. – 2011. – Vol.93-B, N 2. – P. 172-177.253.Peel, T.N. Prosthetic joint infection: challenges of diagnosis and treatment /T.N. Peel, K.L. Buising, P.F. Choong // ANZ J. Surg.
– 2011. – Vol. 81, N 1-2. – P. 3239.254.Penner, M.J. Th e in vi tro elution ch aracteristics of an tibiotic-loaded CM Sand Palacos-R bone cements / M.J. Penner, C.P. Du ncan, B.A. Ma rsi // J. Arthroplasty.– 1999. – Vol. 14, N 2. – P. 209-214.255.Perez-Cardona, P.S. Clinical experience with daptomycin for th e treatmentof patients with kn ee an d hi p periprosthetic joint infections / P.S. Perez-Cardona, V.B.Ojeda, D.R. Pardo [et al.] // J.
Antimicrob. Chemother. – 2012. – Vol. 67, N 7. – P.1749-1754.256.Phillips, C.B. Incidence rates of dislocation, pulmonary embolism, anddeep infection during the first six months after elective total hip replacement / C.B.Phillips, J.A. Barrett, E. Losina [et al.] // J. Bo ne Jo int Surg. – 2003. – Vol.
85-A, N 1.– P. 20–26.172257.Principles of Orthopedic Infection Management / ed. by S. Kates, O.Borens. – Davos : AO Publishing, 2017. P. 189-212.258.Procter, L.D. General surgical operative duration is associated withincreased risk-adjusted infectious complication rates and length of hospital stay / L.D.Procter, D.L. Davenport, A.C. Bernard, J.B. Zwischenberger // J. Am. Coll. Surg. –2010. – Vol. 210, N 1.
– P. 60-65.259.Rasouli, M.R. Risk factors for surgical site infection following total jointarthroplasty / M.R. Rasouli, C. Restrepo, M.G. Maltenfort [et al.] // J. Bone Joint Surg.– 2014. – Vol. 96-A, N 18. – P. e- 158.260.Restrepo, C. Uncemented total hip arthroplasty in patients less than twenty-years / C. Restrepo, T. Lettich, N. Roberts // A ta Orthop.
Belg. – 2008. – Vol. 74, N 5.– P. 615-622.261.Ribera, A. Osteoarticular infection caused by MDR Pseudomonasaeruginosa: the benefits of combination therapy with colistin plus B-lactams /A. Ribera, E. Benavent, J. Lo ra-Tomayo [et al.] // J. Antimicrob. Chemother. – 2015.Vol.
70, N 12. – P. 3357-3365.262.Rogers, B.A. Total hip arthroplasty for adult hip dysplasia / B.A. Rogers, S.Garbedian, R.A. Kuchinad [et al.] // J. Bone Joint Surg. Am. – 2012. – Vol. 94, N 19. –P. 1809-1821.263.Saleh-Mghir, A. Ad junctive ri fampin is cr ucial to op timizing da ptomycinefficacy against rabbit prosthetic joint infection due to methicillin-resistantStaphylococcus aureus / A. Saleh-Mghir, C. Muller-Serieys, A. Dinh [et al.] //Antimicrob.
Agents Chemother. – 2011. – Vol. 55, N 10. – P. 4589-4593.264.Sanchez-Sotelo, J. Midterm to long-term followup of staged reimplantationfor infected hip arthroplasty / J. Sanchez-Sotelo, D.J. Berry, A.D. Hanssen, M.E.Cabanela // Clin. Orthop. Relat. Res. – 2009. – Vol. 467, N 1. – Р. 219-224.265.Sanz-Reig, J. Cementless total hip arthroplasty using titanium, plasma-sprayed implants: a study with 10 to 15 years of follow-up / J. Sanz-Reig, A.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
